View in EDS HTML Full Text PDF Full Text

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.

Saved in:
Bibliographic Details
Title: Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
Authors: Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, alej Svobody 80, 30460, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Giannatempo P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Buti S; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Grillone F; Unità Operativa di Oncologia Presidio Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy., Ürün Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Calabrò F; Medical Oncology, 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bourlon MT; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Escuela de Medicina, Universidad Panamericana, Mexico City, Mexico., Galli L; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy., Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Santini D; Oncologia, Dip, Scienze e Biotecnologie Medico-chirurgiche, Policlinico Umberto 1, Rome, Italy., Yano A; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy., Catalano M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain., Formisano L; Department of Medicine and Surgery, Federico II University, Naples, Italy., Soares A; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Centro Paulista de Oncologia/Oncoclínicas, São Paulo, SP, Brazil., Facchini G; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, Pozzuoli, Naples, Italy., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy., Spinelli GP; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy., Angel M; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina., Stellato M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Tural D; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik, Bakirkoy, Istanbul, Turkey., Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy., Epstein I; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Carrozza F; Oncology Unit, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy., Monteiro FSM; Hospital Sírio-Libanês, Brasília, DF, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Benedetti G; U.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy., Büchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Ortega C; Dipartimento di Oncologia, Ospedale San Lazzaro, Azienda sanitaria locale CN2, Alba, Cuneo, Italy., Zakopoulou R; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Battelli N; Medical Oncology Unit, Macerata Hospital, Macerata, Italy., Porta C; Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari 'Aldo Moro', A.O.U. Consorziale Policlinico di Bari, Bari, Italy., Bellmunt J; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: Targeted oncology [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 905-915. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1776-260X
DOI:10.1007/s11523-024-01099-0